Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brexit Declaration Offers Scant Comfort On Future UK-EU Regulatory Links

Executive Summary

EU leaders have endorsed the “political declaration” outlining the aspirations for the future relationship between the UK and the EU after Brexit, together with the much larger withdrawal deal. The life sciences industry will be disappointed that in the drug regulatory area the political declaration contains little beyond an aspiration for “possible” cooperation between the UK drug regulator and the European Medicines Agency.
Advertisement

Related Content

UK Smooths Clinical Trial Pathway To Reassure Companies With Brexit Jitters
Health Must Be At Center Of Post-Brexit Relationship, Say Industry & NHS Bodies
UK Pharma Takes Hope From Draft Brexit Deal But Uncertainty Reigns
UK Health Committee Wants Clear Answers On Future Links Between MHRA And EMA

Topics

Advertisement
UsernamePublicRestriction

Register

PS124307

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel